蒙特罗莎治疗

最新新闻

• 评级变动
  Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)
  TipRanks · 2026/8/13
• 公司公告
  Lianhuan Pharmaceutical Co., Ltd.: notice of approval of LH-1802 glue for drug clinical trials
  SZSI · 2021/11/8
• 评级变动
  J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $27
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  Wedbush Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $37
  \u5e02\u573a\u8d44\u8baf · 2026/5/9
• 评级变动
  J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $31
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  Jefferies Initiates Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/6/30
• Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT)
  TipRanks · 2026/10/5
• 公司公告
  Poly Glue shares: Tianjiankuan (2022) No. 7-494-Verification report on Poly Glue New Materials Co., Ltd. to invest in fund-raising projects and pay issuance fees in advance with self-raised funds
  SZSI · 2022/9/6
• H.C. Wainwright Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 公司公告
  Dongyue silicon: the company's 107 glue, silicone oil and other products can be used in the field of solar photovoltaic after deep processing.
  SZSI · 2021/9/30
• Piper Sandler Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $37
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• H.C. Wainwright Initiates Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $29
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 公司公告
  AEON Fantasy Co Ltd: It's exactly the same as real. The BIG buffer debut of liquid glue Yamato Aravik will be launched in the online ink game "MOLLY.ONLINE" on Friday, December 3.
  JPX · 2021/12/2
• 公司公告
  AEON Fantasy Co Ltd: Glue Specialty × MOLLY.ONLINE first Cooperative Commodity "Kouyama Yumu" and "Snow Whitening" Limited Cooperative Commodity will start at 18:00 on Monday, August 2nd.
  JPX · 2021/8/2
• 评级变动
  LifeSci Capital Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/2

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。